VOYA Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-67,993
| Closed | -$1.07M | – | 2929 |
|
|
2024
Q1 | $1.07M | Sell |
67,993
-3,524
| -5% | -$54.2K | ﹤0.01% | 1599 |
|
|
2023
Q4 | $1.15M | Buy |
71,517
+50,166
| +235% | +$640K | ﹤0.01% | 1609 |
|
|
2023
Q3 | $272K | Buy |
21,351
+423
| +2% | +$5.84K | ﹤0.01% | 2353 |
|
|
2023
Q2 | $295K | Buy |
20,928
+2,194
| +12% | +$31.4K | ﹤0.01% | 2376 |
|
|
2023
Q1 | $289K | Buy |
18,734
+1,429
| +8% | +$23.9K | ﹤0.01% | 2346 |
|
|
2022
Q4 | $284K | Hold |
17,305
| – | – | ﹤0.01% | 2367 |
|
|
2022
Q3 | $320K | Hold |
17,305
| – | – | ﹤0.01% | 2310 |
|
|
2022
Q2 | $228K | Buy |
17,305
+940
| +6% | +$10.4K | ﹤0.01% | 2322 |
|
|
2022
Q1 | $151K | Buy |
16,365
+1,934
| +13% | +$16.4K | ﹤0.01% | 2431 |
|
|
2021
Q4 | $141K | Sell |
14,431
-5,708
| -28% | -$107K | ﹤0.01% | 2604 |
|
|
2021
Q3 | $685K | Buy |
20,139
+119
| +0.6% | +$3.8K | ﹤0.01% | 1839 |
|
|
2021
Q2 | $733K | Sell |
20,020
-242
| -1% | -$9.37K | ﹤0.01% | 1858 |
|
|
2021
Q1 | $909K | Buy |
20,262
+1,525
| +8% | +$71K | ﹤0.01% | 1656 |
|
|
2020
Q4 | $1.07M | Buy |
18,737
+3,879
| +26% | +$230K | ﹤0.01% | 1472 |
|
|
2020
Q3 | $762K | Buy |
14,858
+1,938
| +15% | +$94.9K | ﹤0.01% | 1436 |
|
|
2020
Q2 | $772K | Buy |
12,920
+2,622
| +25% | +$140K | ﹤0.01% | 1399 |
|
|
2020
Q1 | $424K | Buy |
10,298
+672
| +7% | +$37.3K | ﹤0.01% | 1720 |
|
|
2019
Q4 | $599K | Buy |
9,626
+2,703
| +39% | +$128K | ﹤0.01% | 1790 |
|
|
2019
Q3 | $235K | Buy |
+6,923
| New | +$205K | ﹤0.01% | 2186 |
|
Other funds holding DCPH
VOYA Investment Management's DCPH Position: Q2 2024 in Review
VOYA Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 67,993 shares — an estimated $1.07M sold.
VOYA Investment Management first reported a position in DCPH in Q3 2019 and held it in 19 quarters. The position peaked at $1.15M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- VOYA Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- VOYA Investment Management sold 67,993 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.07M.
- VOYA Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 19 quarters.
- VOYA Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.15M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.